Phototherapy for Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether phototherapy, which involves exposure to bright light, can reduce symptoms like agitation in people with dementia. Participants will either receive bright light therapy or continue with their usual care. The trial seeks patients in a hospital setting with a diagnosis or suspicion of dementia who experience behavioral symptoms like agitation. Those with certain eye conditions, photosensitivity, or recent eye surgery are not eligible. This research aims to discover new ways to support people dealing with challenging dementia symptoms. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could lead to new treatments for dementia symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that phototherapy is safe for people with dementia?
Research has shown that phototherapy, or bright light therapy, is generally safe for people with dementia. Studies have found it can alleviate symptoms like restlessness and sleep disturbances. Importantly, no serious safety concerns are linked to this therapy. For example, one study used a bright light lamp and found it helped individuals with Alzheimer's disease. Another study demonstrated improved cognitive abilities without causing harm. These findings suggest that phototherapy is well-tolerated and does not lead to major side effects, making it a safe option for managing some symptoms of dementia.12345
Why are researchers excited about this trial?
Most treatments for dementia focus on medications that aim to manage symptoms or slow progression, such as cholinesterase inhibitors or memantine. However, phototherapy offers a different approach. It uses bright light therapy, delivered in sessions of 60 minutes, three times a day, for five consecutive days. This method is non-invasive and leverages light to potentially improve cognitive function and mood. Researchers are excited about phototherapy because it could offer a safe, drug-free alternative or complement to current treatments, with the potential for quicker and more natural improvements in patients' quality of life.
What evidence suggests that phototherapy might be an effective treatment for dementia?
Research has shown that phototherapy, also known as bright light therapy, can enhance cognitive abilities in people with dementia. Studies have found that it can also elevate mood and reduce restlessness, common issues for those with dementia. A review of several studies found that phototherapy significantly improved overall mental function. Additionally, bright light therapy has been linked to better sleep and less depression in people with dementia. In this trial, participants in the phototherapy arm will receive bright light therapy, while those in the standard of care group will not receive an intervention. These findings suggest that phototherapy could effectively ease some symptoms of dementia.12345
Who Is on the Research Team?
Stephanie P. Chambers, APRN, CNS
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults with dementia who are in specific hospital units and have symptoms like agitation or other behavioral issues. Participants must be able to give consent themselves or have a legal representative. People with pregnancy, bipolar disorder, serious eye problems, photosensitivity, or recent eye surgery cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the phototherapy arm will receive bright light therapy for 60 minutes, 3 times per day for 5 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Phototherapy
Trial Overview
The study is testing whether phototherapy (exposure to special light) can help reduce behavioral and psychological symptoms in people with dementia. Only one group receives the intervention.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Patients in the phototherapy arm will receive bright light therapy for 60 minutes, 3 times per day for 5 days.
Patients in the standard of care group will not receive an intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Citations
Phototherapy improves cognitive function in dementia - PMC
Our systematic review and meta‐analysis showed that phototherapy significantly improved cognitive function in patients with dementia.
Phototherapy for Cognitive Function in Patients With Dementia
Phototherapy showed significant associations with improvements of global cognitive function (standardized mean difference [SMD], 0.63; 95% ...
The Effects of Light Therapy on Sleep, Depression ...
This meta-analysis demonstrates that light therapy is effective in improving sleep, cognition, and decreasing depression and neuropsychiatric behaviors for PLWD ...
Pilot Study of the Effects of Bright Ambient Therapy on ...
In this pilot study, bright light therapy was more effective than general lighting at improving BPSD and cognitive function among older adults ...
5.
alzheimers.org.uk
alzheimers.org.uk/about-dementia/treatments/alternative-therapies/light-therapy-and-dementiaLight therapy and dementia
One small but well-conducted study showed promising effects of bright light therapy on restlessness and disturbed sleep for people with dementia. A large and ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.